How AI Accelerates Healthcare: Reinventing Clinical Trials

Clinical trials remain to be one of the costliest and slowest parts of drug development.

Unlearn.AI uses artificial intelligence to simulate patient populations and predict patient outcomes. Come join us to learn from Graham Siegel (NU JD ’12), serial entrepreneur and currently COO of Unlearn.AI on how they are using AI to accelerate and reinvent clinical trials. The company recently raised funding led by Data Collective, a leading AI & deep tech venture capital firm that has invested in cutting edge tech startups like Rigetti, Planet Labs, Vicarious and Zymergen. There will be ample time for Q&A to dive deeper into the technology, considerations in joining a startup, raising money for a deep tech startup.